Navigation Links
Beckman Coulter Announces Third Quarter 2007 Results
Date:10/30/2007

rued expenses (3.9) (52.2)

Income taxes payable (18.6) 7.5

Long-term lease receivables 14.5 29.3

Other (11.0) 29.9

Net cash provided by operating activities

of continuing operations* 285.7 234.4

Net cash used in operating activities of

discontinued operations (1.0) (21.3)

Net cash provided by operating

activities * 284.7 213.1

Cash flows from investing activities:

Additions to property, plant and equipment * (223.4) (207.4)

Proceeds from sale of land 30.0 -

Payments for business acquisitions and

technology licenses, net of cash acquired (10.3) (23.9)

Net cash used in investing activities of

continuing operations* (203.7) (231.3)

Net cash provided by investing activities

of discontinued operations 2.6 50.2

Net cash used in investing activities * (201.1) (181.1)

Cash flows from financing activities:

Dividends to stockholders (30.0) (28.2)

Proceeds from issuance of stock 68.3 36.7

Repurchase of common stock as treasury stock (19.9) (87.2)

Repurchase of common stock held in grantor trust (0.7) (0.8)

Excess tax benefits from share-based payment

transactions 18.4 4.6

Debt borrowings, net 8.0 111.4

Debt repayments (122.1)
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... transplant rejection occurs when the transplant recipient,s immune system ... it. It was previously thought that T cells, the ... by molecules known as chemokines in order to migrate ... Journal of Clinical Investigation , Fadi Lakkis and ... demonstrate that chemokine stimulation of T cells is not ...
(Date:5/17/2013)... The new Public-Private Partnership (PPP) in ... association’s recent annual meeting drew praise from community leaders ... who called the action “a huge step forward … ... European innovation.” , The Board of Stakeholders voted to ... PPP at its 29 April meeting in Brussels, which ...
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
(Date:5/17/2013)...  Insero Health, Inc., a company developing natural compounds ... neurological disorders, is today reporting top-line results from a ... patients with drug-resistant epilepsy.  The data are being presented ... meeting by Dr. Steven Schachter , ... Advisory Board.  In this study, INS001 appeared safe and ...
Breaking Biology Technology:SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
... SANTA CLARA, Calif., Oct. 10 Finesse Solutions, ... life science process,applications, is pleased to announce improvements ... and transmitters even easier. The E-Store,can be found ... can now easily purchase bioprocess sensors and accessories,on-line, ...
... ... People, INDIANAPOLIS, Oct. ... it has made the list of Top 20,biopharmaceutical employers, according to the ... in the biotechnology, biopharmaceutical, pharmaceutical and,related industries. This year Lilly ranks number ...
... Technologies announced,today that David E. Kandzari, MD, ... System" during the Drug-Eluting Stent Summit at ... on October 13, 2008. The MiStent(TM), a ... polymer coating that,delivers the potential therapeutic benefits ...
Cached Biology Technology:Lilly Recognized as One of the World's Top Biopharmaceutical Employers 2
(Date:5/16/2013)... Access to Research Careers) Program has announced the ... Biology (SDB) 72nd Annual Meeting in Cancun, Mexico ... to promote the entry of students, postdoctorates and ... the basic science community and to encourage the ... Annual Meeting. , Awards are given to poster/platform ...
(Date:5/16/2013)... shown a gene involved in neurodegenerative disease also plays ... circadian clock. , In a study of the ... Ataxin-2, keeps the clock responsible for sleeping and waking ... of the fruit fly,s sleep-wake cycle is disturbed, making ... fly. , The discovery is particularly interesting because ...
(Date:5/16/2013)... The relationship between the heritable risk for schizophrenia ... Schizophrenia is commonly associated with cognitive impairments that ... reduced IQ may be linked to the risk ... may precede the onset of schizophrenia symptoms. Also, ... of people diagnosed with schizophrenia. , In a ...
Breaking Biology News(10 mins):Gene involved in neurodegeneration keeps clock running 2Genetic risk for schizophrenia is connected to reduced IQ 2
... Blacksburg, Va. Researchers have unveiled the evolutionary ... three species of Agrobacterium. A comprehensive comparison of ... of other bacteria suggests a general model for ... Agrobacteria are members of the Rhizobiaceae family, which ...
... and a fast bite spelled doom for bony fishes during ... a new study to be published March 31, 2009, in ... Today, those same features characterize large predatory bony ... decline and at risk of extinction themselves, said Matt Friedman, ...
... developed at the University of California, Davis to treat ... human clinical trials to evaluate its efficacy. ... is "a first-in-class drug which may treat a suite ... Hammock, who with UC Berkeley cell biologist Sarjeet Gill ...
Cached Biology News:Evolutionary origin of bacterial chromosomes revealed 2Study unravels why certain fishes went extinct 65 million years ago 2Study unravels why certain fishes went extinct 65 million years ago 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 2UC Davis bench-to-bedside research: Promising treatment in clinical trials 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 4UC Davis bench-to-bedside research: Promising treatment in clinical trials 5
...
... to quantitate double-stranded DNA (dsDNA) in solution, even ... this kit, DNA is stained with Hoechst 33258 ... or other fluorometer. The kit quantitates dsDNA in ... 5 micrograms per ml and contains Hoechst 33258, ...
... of colony stimulating factors for assays of ... blood and fetal liver. Suitable for ... and CFU-GEMM when added to methylcellulose at ... of erythropoietin. Will also support growth ...
ImmunoPure Plus Immobilized Protein G, , , , Support: Cross-linked 6%, beaded agarose , Capacity: > 20 mg human IgG/ml of gel ...
Biology Products: